Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease

NCT02087865 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02087865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02087865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2014
Completion date
December 20, 2021
Enrollment
89 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic risk for alzheimer's disease